Diovan

Rediff.com » News » Diovan

News for Diovan

Business

Why Sun Pharma stock will remain under pressure

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......

Sensex ends flat amid choppy trade; Nifty above 7,500

Benchmark indices ended flat, amid a choppy trading session, as investors turned cautious on concerns that the weak monsoon would further accelerate inflation while the continuing crisis in Iraq......

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......

Ranbaxy gets important breather

US FDA removes its earlier shadow on firm's American unit; shift of output & supply from tainted Indian units enabled. Ranbaxy's US factory, Ohm Laboratories, is learnt to have got a clean chit......

US FDA tightens regulatory noose on Indian drug firms

Import alert on Ranbaxy’s Mohali unit; Strides’ injectible arm gets warning letter Indian drug makers have again come under the scrutiny of the US Food and Drug Administration (US FDA),......

Rediff News

Diovan

News for Diovan

Why Sun Pharma stock will remain under pressure

Sensex ends flat amid choppy trade; Nifty above 7,500

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Ranbaxy gets important breather

US FDA tightens regulatory noose on Indian drug firms

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS